z-logo
open-access-imgOpen Access
Balancing the good and the bad: controlling immune-related adverse events versus anti-tumor responses in cancer patients treated with immune checkpoint inhibitors
Author(s) -
Guilherme Ferreira de Britto Evangelista,
Amanda Braga Figueiredo,
Milton Barros,
Kenneth J. Gollob
Publication year - 2022
Publication title -
immunotherapy advances
Language(s) - English
Resource type - Journals
ISSN - 2732-4303
DOI - 10.1093/immadv/ltac008
Subject(s) - medicine , immune checkpoint , immune system , microsatellite instability , immunotherapy , melanoma , cancer , adverse effect , tumor microenvironment , ipilimumab , oncology , cancer immunotherapy , nivolumab , immunology , cancer research , biology , allele , biochemistry , microsatellite , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom